The Global Automated Endoscopy Reprocessor Market, by Product Type (Single Basin and Double Basin), by Modality (Portable and Standalone), by End User (Hospital, Diagnostic Laboratories, and Ambulatory Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 845.3 million in 2017 and is projected to exhibit a CAGR of 6.7% over the forecast period (2018 – 2026). Automated endoscopy reprocessor (AER) market is expected to grow at significant rate, owing to rising number of gastrointestinal (GI) diseases demanding endoscopy procedures.
Increasing demand for endoscopic devices is expected to drive the automated endoscopy reprocessor market growth
Various factors such as rising cases of stomach ulcers, increasing alcohol consumption, lack of proper diet and increasing incidence of autoimmune diseases are contributing to the rise of GI disorders worldwide. Common GI diseases include colorectal cancer, ulcerative colitis, gastro esophageal reflux disease, Crohn’s disease, and inflammatory bowel disease.
Emerging nations are experiencing remarkably high demand for minimally invasive surgical procedures due to increasing disease burden and rising disposable income. However, lack of healthcare professionals skilled in endoscopic procedures and lack of proper medical equipment has created an imbalance between demand and supply. Moreover, a sturdy rise is observed every year in demand for endoscopy in all modern healthcare systems. According to International Journal of Gastroenterology Disorders & Therapy article 2015, about 30 million endoscopic procedures are performed annually in the U.S. Endoscopic products manufacturers are using their technology and services to fulfil this growing demand.
Automated endoscopy reprocessor offer many advantages over manual reprocessing such as automation and standardization of several important reprocessing steps, thus eliminating the chance of missing steps owing to human error, and lessen exposure of endoscopy or sterile processing department personnel to high-level disinfectants (HLDs) or chemical sterilants. Therefore, demand for these products is increasing significantly.
Browse 35 Market Data Tables and 28 Figures spread through 180 Pages and in-depth TOC on “Automated Endoscopy Reprocessor Market, by Product Type (Single Basin and Double Basin), by Modality (Portable and Standalone), by End User (Hospital, Diagnostic Laboratories, and Ambulatory Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026”
To know the latest trends and insights prevalent in the automated endoscopy reprocessor market, click the link below:
Key players in automated endoscopy reprocessor market are investing significantly in new product development and innovations in existing products, and focus on strategic collaboration to enhance their market share. For instance, in April 2018, Cantel Medical received FDA approval to sell its new automated endoscope reprocessor, Advantage Plus Pass-Thru. The device provides high-level disinfection for commonly used endoscopes, including duodenoscopes.
Furthermore, in 2014, Cantel Medical Corp. acquired PuriCore International Ltd., a provider of automated endoscope reprocessors, endoscope drying and storage cabinets, chemistry and consumables for US$ 26.9 million. Moreover, collaborations among manufacturers, accrediting organizations, healthcare providers, professionals, and government organizations can help resolve problems associated with risk of infection transmission, endoscope and AER design, and other issues related to endoscope reprocessing.
Key Takeaways of the Automated Endoscopy Reprocessor Market: